Media headlines about Rite Aid (NYSE:RAD) have been trending somewhat positive on Monday, according to Accern Sentiment. The research group ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Rite Aid earned a coverage optimism score of 0.08 on Accern’s scale. Accern also gave news stories about the company an impact score of 44.3868059690542 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Here are some of the news stories that may have impacted Accern Sentiment Analysis’s analysis:
- No one know's bitcoin's price and the futures contracts might be dead on arrival (finance.yahoo.com)
- Alluring Stock- Rite Aid Corporation (NYSE:RAD) a Drug Stores Company – The Stock Street (press release) (thestreetpoint.com)
- I'll be glued to my trading seat Sunday night when bitcoin futures launch (finance.yahoo.com)
- Rite Aid Co. (RAD) Expected to Post Quarterly Sales of $7.74 Billion (americanbankingnews.com)
- How to Trade these Stock After an unavoidable Selloff: Rite Aid Corporation, (NYSE: RAD), Meritor, Inc., (NYSE: MTOR … – Stocks In The News (press release) (tradingnewsnow.com)
Rite Aid (NYSE:RAD) opened at $1.90 on Monday. Rite Aid has a fifty-two week low of $1.38 and a fifty-two week high of $8.77. The company has a current ratio of 1.74, a quick ratio of 0.77 and a debt-to-equity ratio of 9.71.
Several brokerages recently weighed in on RAD. Royal Bank Of Canada began coverage on Rite Aid in a report on Tuesday, September 19th. They issued a “sector perform” rating and a $2.50 price objective for the company. Loop Capital reissued a “hold” rating and issued a $2.00 price objective (down from $2.50) on shares of Rite Aid in a report on Friday, September 29th. Guggenheim reissued a “neutral” rating and issued a $2.00 price objective on shares of Rite Aid in a report on Monday, October 2nd. Zacks Investment Research lowered Rite Aid from a “hold” rating to a “sell” rating in a report on Wednesday, October 4th. Finally, Deutsche Bank began coverage on Rite Aid in a report on Monday, December 4th. They issued a “hold” rating and a $2.25 price objective for the company. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $3.25.
In other news, Director Myrtle S. Potter sold 28,189 shares of the company’s stock in a transaction that occurred on Tuesday, October 3rd. The stock was sold at an average price of $2.09, for a total transaction of $58,915.01. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.29% of the stock is currently owned by corporate insiders.
ILLEGAL ACTIVITY WARNING: “Rite Aid (RAD) Earns Media Impact Rating of 0.08” was originally published by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The legal version of this article can be read at https://www.com-unik.info/2017/12/11/rite-aid-rad-earns-media-impact-rating-of-0-08.html.
About Rite Aid
Rite Aid Corporation is a retail drugstore chain. The Company’s segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company’s Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog.
What are top analysts saying about Rite Aid Co.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Rite Aid Co. and related companies.